Page Tools:

Dx/Rx: Melanoma

Author(s): Richard D. Carvajal, MD, Medical Oncologist, Memorial Sloan-Kettering Cancer Center, New York, New York
Details:
  • ISBN-13: 9780763773229
  • Paperback    140 pages      © 2011
Price: International Sales $54.95 US List
Add to Cart

Overview

Dx/RX: Melanoma was recently honored with 5 Stars from Doody's Book Review!

Written by a medical oncologist, Dx/Rx: Melanoma is ideal for medical trainees, general practitioners, dermatologists, and medical oncologists. This handy, pocket-sized book provides comprehensive, up-to-date information on the epidemiology, prevention, and management of melanoma of all stages. It includes an in-depth discussion of systemic treatment options in both the adjuvant and metastatic setting, as well as, a look at novel treatment options. Presented in a concise, easy-to-read format, this is an essential reference for on the ward or in the clinic!

Key Features Include:

  • Thorough discussion of systemic therapy of melanoma
  • In-depth look at novel treatments being developed for advanced melanoma, including a discussion of all major recent studies
  • Discussion of the molecular biology of melanoma and the treatment implications

ShowTable of Contents

Chapter  1  Epidemiology and Risk Factors
Chapter  2  Prevention and Screening
Chapter  3  Diagnosis, Staging and Prognosis
Chapter  4  Locoregional Management of In situ and Invasive Melanoma
Chapter  5  Systemic Adjuvant Treatment Options
Chapter  6  Treatment of Metastatic Melanoma
Chapter  7  Emerging Therapeutic Options for Advanced Melanoma
Back to top

ShowAbout the Author(s)

Richard D. Carvajal, MD-Medical Oncologist, Memorial Sloan-Kettering Cancer Center, New York, New York

Dr. Carvajal is a graduate of the University of Pennsylvania in Philadelphia, PA and the New York University School of Medicine in New York, NY. After training in Internal Medicine at the University of Michigan Medical Center, he completed a fellowship in Medical Oncology/Hematology at the Memorial Sloan-Kettering Cancer Center in New York. He subsequently joined the Melanoma/Sarcoma Service at Memorial Sloan-Kettering Cancer Center where he is active in the clinical development of novel therapies for these diseases.

Back to top